Pluri Inc.

PLUR ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2020 FY2019 FY2018
Revenue $1.0M $1.3M $326.0K $287.0K $234.0K $23.0K $54.0K $50.0K
Cost of Revenue $563.0K $682.0K $4.0K $9.0K $2.0K $2.0K
Gross Profit $453.0K $654.0K $322.0K $278.0K $234.0K $23.0K $52.0K $48.0K
Gross Margin 44.6% 49.0% 98.8% 96.9% 100.0% 100.0% 96.3% 96.0%
Operating Expenses
Research & Development $15.1M $12.9M $12.4M $15.7M $24.6M $23.1M $29.9M $26.4M
SG&A Expense $10.3M $10.0M $10.0M $11.8M $17.5M $7.9M $9.2M $11.2M
Operating Income $-24.9M $-22.2M $-22.2M $-27.2M $-41.6M $-29.5M $-35.5M $-33.7M
Operating Margin -2,454.5% -1,659.9% -6,796.9% -9,493.4% -17,774.8% -128,156.5% -65,800.0% -67,462.0%
Interest Expense $866.0K $843.0K $887.0K
Pretax Income $-25.4M $-23.3M $-21.3M
Income Tax Expense $-25.0K $-5.0K
Net Income $-23.8M $-22.6M $-20.9M $-28.3M $-41.2M $-29.2M $-35.3M $-26.1M
Net Margin -2,344.6% -1,690.3% -6,407.4% -9,867.9% -17,624.8% -126,747.8% -65,383.3% -52,252.0%
EPS (Basic) $-2.44 $-3.56 $-3.99 $-6.24 $-1.28 $-1.60 $-2.90 $-2.50
EPS (Diluted) $-2.44 $-3.56 $-3.99 $-6.24 $-1.28 $-1.60 $-2.90 $-2.50
Shares Outstanding (Basic) 9.7M 6.3M 5.2M 4.6M 32.2M 25.6M 15.5M 113.6M
Shares Outstanding (Diluted) 9.7M 6.3M 5.2M 4.6M 32.2M 25.6M 15.5M 113.6M
Dividends Per Share
← Newer Page 1 of 2 Older →